
### [MONDO:0018796](http://purl.obolibrary.org/obo/MONDO_0018796)
**Label:** isolated constitutional thrombocytopenia

**Subclasses:** [MONDO:0017057](http://purl.obolibrary.org/obo/MONDO_0017057) (hereditary thrombocytopenia with normal platelets), [MONDO:0018268](http://purl.obolibrary.org/obo/MONDO_0018268) (Medich giant platelet syndrome), [MONDO:0009276](http://purl.obolibrary.org/obo/MONDO_0009276) (Bernard-Soulier syndrome), [MONDO:0018269](http://purl.obolibrary.org/obo/MONDO_0018269) (white platelet syndrome), [MONDO:0010120](http://purl.obolibrary.org/obo/MONDO_0010120) (THC3), [MONDO:0015372](http://purl.obolibrary.org/obo/MONDO_0015372) (autosomal dominant macrothrombocytopenia), [MONDO:0016361](http://purl.obolibrary.org/obo/MONDO_0016361) (isolated hereditary giant platelet disorder), [MONDO:0011071](http://purl.obolibrary.org/obo/MONDO_0011071) (hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome), [MONDO:0019031](http://purl.obolibrary.org/obo/MONDO_0019031) (thrombocytopenia with congenital dyserythropoietic anemia), [MONDO:0007686](http://purl.obolibrary.org/obo/MONDO_0007686) (gray platelet syndrome), [MONDO:0010444](http://purl.obolibrary.org/obo/MONDO_0010444) (X-linked dyserythropoetic anemia with abnormal platelets and neutropenia), [MONDO:0011136](http://purl.obolibrary.org/obo/MONDO_0011136) (Quebec platelet disorder), [MONDO:0015679](http://purl.obolibrary.org/obo/MONDO_0015679) (autosomal thrombocytopenia with normal platelets), [MONDO:0010743](http://purl.obolibrary.org/obo/MONDO_0010743) (X-linked thrombocytopenia with normal platelets), [MONDO:0014830](http://purl.obolibrary.org/obo/MONDO_0014830) (platelet-type bleeding disorder 20), [MONDO:0013141](http://purl.obolibrary.org/obo/MONDO_0013141) (autosomal dominant macrothrombocytopenia TUBB1-related), [MONDO:0016630](http://purl.obolibrary.org/obo/MONDO_0016630) (isolated delta-storage pool disease), [MONDO:0014078](http://purl.obolibrary.org/obo/MONDO_0014078) (platelet-type bleeding disorder 15), [MONDO:0008553](http://purl.obolibrary.org/obo/MONDO_0008553) (platelet-type bleeding disorder 17), [MONDO:0008555](http://purl.obolibrary.org/obo/MONDO_0008555) (thrombocytopenia 2), [MONDO:0008557](http://purl.obolibrary.org/obo/MONDO_0008557) (Paris-Trousseau thrombocytopenia), [MONDO:0020117](http://purl.obolibrary.org/obo/MONDO_0020117) (alpha granule disease), [MONDO:0007930](http://purl.obolibrary.org/obo/MONDO_0007930) (Bernard-Soulier syndrome, type A2, autosomal dominant), [MONDO:0012775](http://purl.obolibrary.org/obo/MONDO_0012775) (thrombocytopenia 4), [MONDO:0014518](http://purl.obolibrary.org/obo/MONDO_0014518) (platelet-type bleeding disorder 19), [MONDO:0014536](http://purl.obolibrary.org/obo/MONDO_0014536) (thrombocytopenia 5), [MONDO:0013524](http://purl.obolibrary.org/obo/MONDO_0013524) (bleeding diathesis due to thromboxane synthesis deficiency), [MONDO:0011469](http://purl.obolibrary.org/obo/MONDO_0011469) (congenital amegakaryocytic thrombocytopenia), 

**Corr. equiv. classes:** [OMIM:188025](http://purl.obolibrary.org/obo/OMIM_188025), [OMIM:601399](http://purl.obolibrary.org/obo/OMIM_601399), [Orphanet:248340](http://www.orpha.net/ORDO/Orphanet_248340), [OMIM:188000](http://purl.obolibrary.org/obo/OMIM_188000), [Orphanet:67044](http://www.orpha.net/ORDO/Orphanet_67044), [OMIM:616176](http://purl.obolibrary.org/obo/OMIM_616176), [OMIM:139090](http://purl.obolibrary.org/obo/OMIM_139090), [Orphanet:220452](http://www.orpha.net/ORDO/Orphanet_220452), [Orphanet:168629](http://www.orpha.net/ORDO/Orphanet_168629), [OMIM:601709](http://purl.obolibrary.org/obo/OMIM_601709), [OMIM:231200](http://purl.obolibrary.org/obo/OMIM_231200), [Orphanet:466806](http://www.orpha.net/ORDO/Orphanet_466806), [Orphanet:3319](http://www.orpha.net/ORDO/Orphanet_3319), [OMIM:616216](http://purl.obolibrary.org/obo/OMIM_616216), [OMIM:616913](http://purl.obolibrary.org/obo/OMIM_616913), [Orphanet:852](http://www.orpha.net/ORDO/Orphanet_852), [Orphanet:851](http://www.orpha.net/ORDO/Orphanet_851), [Orphanet:98455](http://www.orpha.net/ORDO/Orphanet_98455), [Orphanet:220436](http://www.orpha.net/ORDO/Orphanet_220436), [Orphanet:370127](http://www.orpha.net/ORDO/Orphanet_370127), [OMIM:187900](http://purl.obolibrary.org/obo/OMIM_187900), [OMIM:313900](http://purl.obolibrary.org/obo/OMIM_313900), [OMIM:273900](http://purl.obolibrary.org/obo/OMIM_273900), [OMIM:604498](http://purl.obolibrary.org/obo/OMIM_604498), [Orphanet:274](http://www.orpha.net/ORDO/Orphanet_274), [Orphanet:71290](http://www.orpha.net/ORDO/Orphanet_71290), [OMIM:153670](http://purl.obolibrary.org/obo/OMIM_153670), [OMIM:615193](http://purl.obolibrary.org/obo/OMIM_615193), [OMIM:300835](http://purl.obolibrary.org/obo/OMIM_300835), [Orphanet:140957](http://www.orpha.net/ORDO/Orphanet_140957), [Orphanet:220443](http://www.orpha.net/ORDO/Orphanet_220443), [Orphanet:268322](http://www.orpha.net/ORDO/Orphanet_268322), [Orphanet:363727](http://www.orpha.net/ORDO/Orphanet_363727), [OMIM:613112](http://purl.obolibrary.org/obo/OMIM_613112), [OMIM:612004](http://purl.obolibrary.org/obo/OMIM_612004), [Orphanet:438207](http://www.orpha.net/ORDO/Orphanet_438207), [Orphanet:370131](http://www.orpha.net/ORDO/Orphanet_370131), [OMIM:614009](http://purl.obolibrary.org/obo/OMIM_614009), [Orphanet:721](http://www.orpha.net/ORDO/Orphanet_721), 

**Class expressions from DL-Learner:**

- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001933](http://purl.obolibrary.org/obo/HP_0001933) (Subcutaneous hemorrhage) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0001933](http://purl.obolibrary.org/obo/HP_0001933) (Subcutaneous hemorrhage) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 46.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 46.49%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) 46.49%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 45.53%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 44.44%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 44.44%


